Domenico Galetta

Chemotherapy for Elderly Patients With Advanced Non-Small-Cell Lung Cancer: The Multicenter Italian Lung Cancer in the Elderly Study (MILES) Phase III Randomized Trial

C. Gridelli, Federica Perrone, Ciro Gallo et al. · JNCI Journal of the National Cancer Institute · 2003 · 795 citations · Full text

Ramucirumab plus erlotinib in patients with untreated, EGFR-mutated, advanced non-small-cell lung cancer (RELAY): a randomised, double-blind, placebo-controlled, phase 3 trial

Kazuhiko Nakagawa, Edward B. Garon, Takashi Seto et al. · The Lancet Oncology · 2019 · 594 citations · Full text

Medicine, Pathology, Immune Checkpoint Inhibitor +5

Long-term results of endoscopic thoracic sympathectomy for upper limb hyperhidrosis

Dominique Gossot, Domenico Galetta, Antoine Pascal et al. · The Annals of Thoracic Surgery · 2003 · 222 citations

Medicine, Surgery, Dermatology +1

Grading the neuroendocrine tumors of the lung: an evidence-based proposal

Guido Rindi, Catherine Klersy, Frediano Inzani et al. · Endocrine Related Cancer · 2013 · 210 citations · Full text

World Health Organization, Surgical Oncology, Lung Neuroendocrine Tumors +22

Crizotinib in <i>MET</i> -Deregulated or <i>ROS1</i> -Rearranged Pretreated Non–Small Cell Lung Cancer (METROS): A Phase II, Prospective, Multicenter, Two-Arms Trial

Lorenza Landi, Rita Chiari, Marcello Tiseo et al. · Clinical Cancer Research · 2019 · 183 citations · Full text